Healthcare · Hospital Chain (Maternity & Child Care)
Awaiting a verified source quote. No third-party quote is on record for this company yet, so there is no indicative price to show — and we would rather leave it blank than print a number we cannot stand behind. Our team can confirm the current dealable level directly.
Indicative private-market reference — not an exchange quote. Not investment advice.
Two separate things, deliberately shown side by side: a sourced private-market price reference, and the depth of research that actually stands behind this company today.
No third-party quote has been sourced for this company yet, so there is no market reference to show. Ask us to check the current level and we will come back with what the market is actually doing.
Real, dated third-party observations only — plotted where they exist, never interpolated, extended or carried forward. This is a record of private-market sightings, not a live exchange chart.
Price history not available. No dated third-party quotes have been sourced for this company yet.
Assembled only from records that exist for this company. Anything not disclosed says so.
Cloudnine is a specialised women-and-child healthcare hospital chain in India, focused on maternity, gynaecology, fertility (IVF), paediatrics and neonatal intensive care, operating more than 40 centres across 15+ cities including Bengaluru, Mumbai, Delhi-NCR, Chennai and Hyderabad. It was founded in Bengaluru in 2007 by neonatologist Dr. R. Kishore Kumar. The chain filed for an IPO in 2022 but did not proceed; as of 2026 global private-equity firms including TPG NewQuest, Advent International, CVC Capital Partners and Permira are reportedly bidding for a stake at a valuation exceeding Rs. 11,000 crore.
Source: The Ken / Cloudnine (official)Competes with Motherhood Hospitals and listed paediatric-focused Rainbow Children's Medicare, as well as Apollo Cradle, in India's maternity and child-care hospital segment.
Source: Not attributedFounder-led with institutional ownership built up over multiple funding rounds (past investors include True North and Sequoia Capital); as of 2026 global PE firms are bidding for a controlling stake
Promoters & principal holders: Dr. R. Kishore Kumar
Unlisted; withdrew a 2022 IPO attempt and is now pursuing a private-equity stake sale instead
We would rather say that plainly than publish a page that looks finished.
No financials, no implied valuation and no peer comparison have been researched for this company yet.
No Prospera Private Market Score and no Prospera view exist. Being in our universe is not a recommendation, and we will not manufacture one to fill this space.
What you can rely on above is what has actually been verified: the company's identity and business facts, any sourced price observations on record, and any risks that have been documented. If you want us to prioritise deeper work here, ask — that is genuinely how the queue gets set.
Documented, per-company risks — grouped by the categories the research itself recorded. There is no risk score here, because we do not compute one.
Cloudnine already tried and failed to build sufficient investor confidence for a public listing around 2022, and has since pivoted toward a private-equity stake sale rather than relisting for an IPO.
Source: The KenDated, sourced events only — recorded as they were reported, in reverse order of significance to a private-market holder.
Agrees to take over Apollo Health and Lifestyle's maternity, childcare and fertility operations
Significantly expands Cloudnine's footprint and scale ahead of a potential new PE-backed ownership structure.
Source: The KenFiles draft IPO papers with SEBI
First attempt to list, at a valuation of roughly Rs. 4,000 crore; the offering was later not pursued to completion.
Source: Business StandardEvery figure on this page comes from one of the records below. Where a source published a link, it is here.
| Field | Source | As of |
|---|---|---|
| Business Description | The Ken / Cloudnine (official) | Not disclosed |
| Competitive Position | Not attributed | Not disclosed |
Every option below opens a conversation with a person at Prospera. Nothing here places, reserves or executes an order.
We will come back with the current dealable level, the available lot size and what the process actually involves. Indicative prices shown on this page are private-market references, not executable quotes.